medigraphic.com
SPANISH

Revista de Hematología

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2015, Number 2

<< Back Next >>

Rev Hematol Mex 2015; 16 (2)

Modified chromogenic method to assess anti-Xa activity in jaundiced patients

García-de Paoletti DN, Paoletti ME, Paoletti EA, Aloni-Risana E, Soto JG, Barassi CA, Pereyra MA, Cerviño MF, Suárez-González L, Mielgo D
Full text How to cite this article

Language: English
References: 7
Page: 121-127
PDF size: 614.15 Kb.


Key words:

anti-Xa activity, jaundice, modified chromogenic method.

ABSTRACT

Objective: To propose a modification of the chromogenic conventional method (Rorachrom Heparin Stago’s Method) to be used in patients with jaundice.
Material and method: An analytic epidemiological study was made. We compared the values of anti-Xa activity in 40 patients with jaundice and without jaundice using a modified chromogenic conventional method. The Pearson coefficient correlation was calculated.
Results: The absorbance of each reading was concurrent with the concentration of low molecular weight heparin added in each tube is not modified by the value of bilirubin with the pNA. The adaptation mentioned could be used in jaundice newborn achieving a more exact measurement of blood level of heparin.
Conclusions: The modified chromogenic conventional method is an excellent tool to have into consideration to measure anti-Xa in patients with jaundice.


REFERENCES

  1. Kitchen S, Iampietro R, Woolley AM, Preston FE. Anti-Xa monitoring during treatment with low molecular weight heparin or danaparoid: inter-assay variability. Thromb Haemost 1999; 82:1289-1293.

  2. Depasse F, Gilbert M, Goret V, Rolland N, Samama MM. Anti-Xa monitoring: inter-assay variability. Thromb Haemost 2000;84:1122-1123.

  3. Kovacs MJ, Keeney M. Inter-assay and instrument variability of anti-Xa results. Thromb Haemost 2000;84:138.

  4. Greaves M. Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis. Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: on behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis. Thromb Haemost. 2002;87:163-164.

  5. Instructions of preparation of Kit made by Stago.

  6. Lide, David R. Handbook of chemistry and physics. 84th ed. Florida: CRC Press, 2003-2004.

  7. Mc-Murray J. Reacciones de copulación de las sales de diazonio. Química orgánica. 6th ed. México: Thomson International Group, 2004;920-921.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Hematol Mex. 2015;16